Qrtly report as at end March seems to hold nothing really new and tangible.
Cash then was $1.2M with a cash burn of over $600k per qtr.
Still seem to be struggling to supply the Euro $50,000 Egyptian order. Seems little prospect of significant sales before the cash gets critical again in a few months.
Lots of activity and R&D/commercialization but very few commercial results measured by revenue. The company seems unable to move out of this phase to real commercial activity and revenue. Why?
Why is the Egyptian deal taking so long to consumate?
Am I missing something in this qtrly that gives us hope?
Ann: Appendix 4C - quarterly and commentary , page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
